Associated Papers
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors.
Ntemgwa M et al.
Antimicrobial Agents and Chemotherapy, 2007
Select a paper to view details